JACOBS LEVY EQUITY MANAGEMENT, INC - AXSOME THERAPEUTICS INC ownership

AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 67 filers reported holding AXSOME THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.52 and the average weighting 0.4%.

Quarter-by-quarter ownership
JACOBS LEVY EQUITY MANAGEMENT, INC ownership history of AXSOME THERAPEUTICS INC
ValueSharesWeighting
Q4 2019$4,386,000
+191.8%
42,438
-42.9%
0.04%
+138.9%
Q3 2019$1,503,000
-21.4%
74,2650.0%0.02%
-30.8%
Q2 2019$1,912,000
+80.9%
74,2650.0%0.03%
+73.3%
Q1 2019$1,057,000
+346.0%
74,265
-11.8%
0.02%
+275.0%
Q4 2018$237,000
+8.2%
84,165
+32.8%
0.00%
+33.3%
Q3 2018$219,00063,3650.00%
Other shareholders
AXSOME THERAPEUTICS INC shareholders Q1 2019
NameSharesValueWeighting ↓
ALETHEA CAPITAL MANAGEMENT, LLC 758,794$53,032,11365.14%
Fairmount Funds Management LLC 2,341,238$163,629,12419.69%
Ally Bridge Group (NY) LLC 110,600$7,729,8349.07%
RTW INVESTMENTS, LP 4,489,596$313,777,8646.62%
SVB FINANCIAL GROUP 33,849$2,365,7074.45%
BVF INC/IL 2,131,100$148,942,5794.02%
Altium Capital Management LP 92,000$6,429,8803.35%
Tri Locum Partners LP 142,510$9,960,0243.18%
TANG CAPITAL MANAGEMENT LLC 320,000$22,364,8003.16%
Deep Track Capital, LP 1,140,745$79,726,6683.08%
View complete list of AXSOME THERAPEUTICS INC shareholders